Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation in Healthy Male Volunteers

NCT02180477 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: UHAC 62 XX - TF1 tablet
DRUG: UHAC 62 XX - TF2 tablet
DRUG: UHAC 62 XX - capsules

Sponsor

Boehringer Ingelheim